The Membrane-spanning Domains of Caveolins-1 and -2 Mediate the Formation of Caveolin Hetero-oligomers
暂无分享,去创建一个
[1] J. Engelman,et al. Sequence and detailed organization of the human caveolin‐1 and ‐2 genes located near the D7S522 locus (7q31.1) , 1999, FEBS letters.
[2] J. Engelman,et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. , 1998, American journal of human genetics.
[3] J. Engelman,et al. Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis* , 1998, The Journal of Biological Chemistry.
[4] J. Engelman,et al. Targeted downregulation of caveolin‐1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade , 1998, The EMBO journal.
[5] J. Engelman,et al. Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers , 1998, FEBS letters.
[6] J. Engelman,et al. Mutational analysis of caveolin‐induced vesicle formation , 1998, FEBS letters.
[7] J. Engelman,et al. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3) , 1998, FEBS letters.
[8] F. Zara,et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.
[9] M. Lisanti,et al. Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.
[10] K. Uzawa,et al. Localization of a tumour‐suppressor gene associated with human oral cancer on 7q31.1 , 1998, International journal of cancer.
[11] P. Scheiffele,et al. Caveolin-1 and -2 in the Exocytic Pathway of MDCK Cells , 1998, The Journal of cell biology.
[12] Haojie Huang,et al. Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer , 1998, Genes, chromosomes & cancer.
[13] E. Bergstralh,et al. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer , 1998, Genes, chromosomes & cancer.
[14] M. Lisanti,et al. Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins , 1997, The Journal of Biological Chemistry.
[15] David I. Smith,et al. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas , 1997, Oncogene.
[16] E. V. van Donselaar,et al. Cell-type and Tissue-specific Expression of Caveolin-2 , 1997, The Journal of Biological Chemistry.
[17] Charles C. Wykoff,et al. Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.
[18] M. Lisanti,et al. Molecular and cellular biology of caveolae paradoxes and plasticities. , 1997, Trends in cardiovascular medicine.
[19] Carl W. Miller,et al. Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer , 1997, Genes, chromosomes & cancer.
[20] Tsuneya Ikezu,et al. Identification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain , 1997, The Journal of Biological Chemistry.
[21] M. Lisanti,et al. Mutational Analysis of the Properties of Caveolin-1 , 1997, The Journal of Biological Chemistry.
[22] T. Katada,et al. Identification, Sequence, and Expression of an Invertebrate Caveolin Gene Family from the Nematode Caenorhabditis elegans , 1997, The Journal of Biological Chemistry.
[23] S. S. Koh,et al. Baculovirus-based Expression of Mammalian Caveolin in Sf21 Insect Cells , 1996, The Journal of Biological Chemistry.
[24] S. Scherer,et al. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. , 1996, Oncogene.
[25] A. Scarpa,et al. Chromosome 7q allelic losses in pancreatic carcinoma. , 1996, Cancer research.
[26] M. Lisanti,et al. Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[27] M. Lisanti,et al. Phosphorylation of Caveolin by Src Tyrosine Kinases , 1996, The Journal of Biological Chemistry.
[28] H. Lodish,et al. Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.
[29] H. Lodish,et al. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Lisanti,et al. Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Bostwick,et al. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. , 1995, Cancer research.
[32] R. Parton,et al. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Zenklusen,et al. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. , 1995, Oncogene.
[34] H. Lodish,et al. Caveolin Isoforms Differ in Their N-terminal Protein Sequence and Subcellular Distribution. IDENTIFICATION AND EPITOPE MAPPING OF AN ISOFORM-SPECIFIC MONOCLONAL ANTIBODY PROBE (*) , 1995, The Journal of Biological Chemistry.
[35] F. Vogel,et al. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. , 1995, Molecular biology of the cell.
[36] M. Lisanti,et al. Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin , 1995, The Journal of Biological Chemistry.
[37] I. Bièche,et al. 452 Loss of heterozygosity on 7Q31 occurs early during breast tumorigenesis , 1995 .
[38] D. Dietzen,et al. Caveolin Is Palmitoylated on Multiple Cysteine Residues , 1995, The Journal of Biological Chemistry.
[39] J. Zenklusen,et al. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. , 1995, Cancer research.
[40] P. Troncoso,et al. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. , 1994, Cancer research.
[41] I. Bièche,et al. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Lodish,et al. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles , 1994, The Journal of cell biology.
[43] M. Lisanti,et al. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. , 1994, Trends in cell biology.
[44] B. Neel,et al. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.
[45] G. Raposo,et al. Caveolae and sorting in the trans‐Golgi network of epithelial cells. , 1993, The EMBO journal.
[46] R. Kurman,et al. Cytogenetic profile of uterine sarcomas , 1993, Cancer.
[47] H. Lodish,et al. Cloning of a Rab3 isotype predominantly expressed in adipocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[48] I. Bièche,et al. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer , 1992, The Lancet.
[49] N. Severs,et al. Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? , 1988, Journal of cell science.
[50] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.
[51] K. Shiga,et al. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma. , 1998, Anticancer research.